Infantile-onset inflammatory bowel disease has variable long-term outcomes

Objective and aimInfantile-onset inflammatory bowel disease (IO-IBD), defined as IBD diagnosed at age 2 years or younger, tends to be more severe and refractory to conventional treatment than IBD diagnosed at a later age. However, data about IO-IBD and its long-term follow up are limited. We thus ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Alex Krauthammer (Author), Ilana Weintraub (Author), Ron Shaoul (Author), Raffi Lev-Tzion (Author), Efrat Broide (Author), Michael Wilschanski (Author), Aaron Lerner (Author), Baruch Yerushalmi (Author), Dror S. Shouval (Author), Hussein Shamaly (Author), Yael Haberman-Ziv (Author), Batia Weiss (Author)
Format: Book
Published: Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9aed0ed6d30c4e6e89bd1ca1114c6710
042 |a dc 
100 1 0 |a Alex Krauthammer  |e author 
700 1 0 |a Alex Krauthammer  |e author 
700 1 0 |a Ilana Weintraub  |e author 
700 1 0 |a Ron Shaoul  |e author 
700 1 0 |a Raffi Lev-Tzion  |e author 
700 1 0 |a Efrat Broide  |e author 
700 1 0 |a Michael Wilschanski  |e author 
700 1 0 |a Aaron Lerner  |e author 
700 1 0 |a Baruch Yerushalmi  |e author 
700 1 0 |a Dror S. Shouval  |e author 
700 1 0 |a Hussein Shamaly  |e author 
700 1 0 |a Yael Haberman-Ziv  |e author 
700 1 0 |a Yael Haberman-Ziv  |e author 
700 1 0 |a Batia Weiss  |e author 
700 1 0 |a Batia Weiss  |e author 
245 0 0 |a Infantile-onset inflammatory bowel disease has variable long-term outcomes 
260 |b Frontiers Media S.A.,   |c 2023-03-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2023.1097779 
520 |a Objective and aimInfantile-onset inflammatory bowel disease (IO-IBD), defined as IBD diagnosed at age 2 years or younger, tends to be more severe and refractory to conventional treatment than IBD diagnosed at a later age. However, data about IO-IBD and its long-term follow up are limited. We thus aimed to evaluate the presentation and long-term outcomes of patients with IO-IBD in a retrospective multicenter study.MethodsMedical records of patients diagnosed with IO-IBD in eight medical centers during 2000-2017 with at least 1-year follow up were reviewed. Demographics and disease characteristics at diagnosis including age of onset, disease phenotype and location, surgeries, medical therapy, and comorbid conditions were recorded.ResultsTwenty-three patients with IO-IBD (16 males, 70%) were identified and followed for a median (range) of 51.2 (26.0-110.3) months. The mean ages at presentation and at the last follow up were 14 ± 9.8 and 101 ± 77 months, respectively. Six (26%) patients needed ileostomy already at the time of diagnosis and 20 (87%) were treated with corticosteroids. During long-term follow up, remission was achieved in 16 (73%) patients; of whom, 3 (14%) were without medications and 7 (32%) were in remission with the use of 5-aminosalicylic acid only. One patient needed hemicolectomy and one developed a severe EBV related infection.ConclusionThe majority of patients with IO-IBD achieved long-term remission, despite a severe disease presentation at diagnosis. Surgery rate however is high, mainly during the first months from diagnosis. 
546 |a EN 
690 |a inflammatory bowel disease 
690 |a infantile onset 
690 |a remission 
690 |a surgery 
690 |a long-term outcome 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 11 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fped.2023.1097779/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/9aed0ed6d30c4e6e89bd1ca1114c6710  |z Connect to this object online.